Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$35.48 USD
-0.46 (-1.28%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $35.49 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
COLL 35.48 -0.46(-1.28%)
Will COLL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for COLL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for COLL
Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know
Humana (HUM), DUOS Unveil Program to Improve Veterans' Health
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
Other News for COLL
Commit To Purchase Collegium Pharmaceutical At $17.50, Earn 6.7% Annualized Using Options
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
Collegium Pharmaceutical to redeem outstanding 2.625% convertible senior notes due 2026
Collegium Pharmaceutical announces redemption of convertible senior notes